Retail entity
Every one of those 1 sits in a single category, market-trends. Amai Proteins is most often covered alongside FDA, which appears in 1 of these 1 story. At 7, the average consequence score sits above the same-window beat average of 5.9.
Last mentioned: Feb 19, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, market-trends. Amai Proteins is most often covered alongside FDA, which appears in 1 of these 1 story. At 7, the average consequence score sits above the same-window beat average of 5.9. Source depth averages 2 original sources per story, versus 2.3 across the same-window beat baseline. We currently track 1 Retail story that mention Amai Proteins, all published on February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 28 Retail stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Amai Proteins. Shared-story counts are live from our verified record — not editorial picks.
Amai Proteins has achieved a major regulatory milestone with the U.S. FDA’s GRAS approval for Sweelin, its designer protein sweetener. This clearance allows for the immediate integration of the sugar alternative into the U.S. food and beverage supply chain, targeting a $100 billion sugar-reduction market.
Source: perishablenews.com · It비즈뉴스
Amai Proteins is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
